Retroperitoneal sarcoma

الأقسام والتخصصات

تضم Mayo Clinic أكبر العيادات وأكثرها خبرة في الولايات المتحدة الأمريكية، وتوجد فروعها في ولاية أريزونا وفلوريدا ومينيسوتا. ويتعاون كادرها الماهر المكون من عدة تخصصات لضمان تقديم علاج ناجح ورعاية عالية الجودة.

الأقسام التي تعالج هذه الحالة

نطاقات البحث المختصة بهذه الحالة

الأبحاث

Mayo Clinic is advancing research in retroperitoneal sarcoma through multidisciplinary efforts that combine surgical oncology, translational science and precision medicine. Faculty members are investigating the molecular characteristics of retroperitoneal sarcomas using next-generation sequencing technologies to better understand why these tumors recur after surgical removal and to identify potential new therapeutic targets. This research aims to develop more personalized treatment approaches by integrating genomic information from both the tumor and its microenvironment.

In addition, Mayo Clinic also conducts clinical and translational research focused on sarcoma surgery and treatment sequencing, evaluating strategies that improve outcomes and reduce complications for patients undergoing complex sarcoma resections. Together, these efforts reflect Mayo Clinic's commitment to improving the diagnosis, surgical management and long-term outcomes of patients with retroperitoneal sarcoma through innovative research and multidisciplinary care.

Cancer research is conducted in coordination with Mayo Clinic Comprehensive Cancer Center. Mayo Clinic Comprehensive Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center. This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.